SenesTech, Inc. (SNES)

NASDAQ: SNES · Real-Time Price · USD
1.460
-0.020 (-1.35%)
At close: Apr 28, 2026, 4:00 PM EDT
1.580
+0.120 (8.22%)
After-hours: Apr 28, 2026, 4:02 PM EDT
-1.35%
Market Cap 7.74M
Revenue (ttm) 2.22M
Net Income (ttm) -6.38M
Shares Out 5.30M
EPS (ttm) -1.95
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,139
Open 1.479
Previous Close 1.480
Day's Range 1.440 - 1.510
52-Week Range 1.410 - 6.240
Beta 0.25
Analysts n/a
Price Target n/a
Earnings Date May 7, 2026

About SNES

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the act... [Read more]

Sector Materials
IPO Date Dec 8, 2016
Employees 24
Stock Exchange NASDAQ
Ticker Symbol SNES
Full Company Profile

Financial Performance

In 2025, SenesTech's revenue was $2.22 million, an increase of 19.60% compared to the previous year's $1.86 million. Losses were -$6.38 million, 3.22% more than in 2024.

Financial Statements

News

SenesTech Earnings Call Transcript: Q4 2025

Revenue grew 20% to $2.2M in 2025, with e-commerce up 88% and gross margin rising to 62.5%. Adjusted net loss improved, and the company resolved major litigation, expanded internationally, and is targeting accelerated growth in 2026.

6 weeks ago - Transcripts

SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth qu...

6 weeks ago - PRNewsWire

SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth ...

7 weeks ago - PRNewsWire

SenesTech Reports Significant Reductions in Rodent Activity Following Evolve® Deployments in Urban Field Studies

SURPRISE, Ariz., Feb. 18, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ("SenesTech" or the "Company"), a leader in birth control solutions for managing rodent populations, today reported signif...

2 months ago - PRNewsWire

SenesTech Strengthens Direct-to-Consumer Commercial Strategy by Directly Managing Amazon Sales of Evolve™ Rat and Evolve™ Mouse

Transition from Third-Party to Internal Management Expected to Increase Revenue and Enhance Margin on E-Commerce Channel Moving Forward While Building on Early Success PHOENIX, Feb. 10, 2026 /PRNewswi...

2 months ago - PRNewsWire

SenesTech's Evolve® Approved in New Zealand

Supporting New Zealand's Predator Free 2050 Initiative Initial Stocking Order Fulfilled PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions f...

3 months ago - PRNewsWire

SenesTech Announces CEO Transition Plan

Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTe...

3 months ago - PRNewsWire

SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve® Rat Birth Control

SURPRISE, Ariz. , Nov. 11, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the pioneer in fertility control for managing animal pest populations, proudly announces the addition of Sarah Mann and ...

6 months ago - PRNewsWire

SenesTech Earnings Call Transcript: Q3 2025

Record Q3 revenue was driven by strong e-commerce, retail, and municipal growth, with gross margins at 63% and adjusted EBITDA loss at a historic low. The company maintains a solid cash position and expects continued expansion, including international markets and new retail partnerships.

6 months ago - Transcripts

SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA

77% Revenue Growth in Evolve® Rodent Birth Control™ Products Strong Cash Balance and Progress Toward Profitability SURPRISE, Ariz. , Nov. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the l...

6 months ago - PRNewsWire

SenesTech's Evolve® Rat Birth Control® Now Available Online at Lowes.com

E-Commerce Presence Marks a Gateway to In-Store Opportunities for Evolve™ SURPRISE, Ariz. , Nov. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing a...

6 months ago - PRNewsWire

SenesTech to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX , Nov. 3, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fert...

6 months ago - PRNewsWire

Swampscott Launches Pilot of SenesTech's Innovative Rat Birth Control at Firehouse and Local School

SWAMPSCOTT, Mass. , Oct. 13, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for pest management, today announced the Town of Swampscott has launched a groundbreak...

7 months ago - PRNewsWire

SenesTech Transcript: Lytham Partners Fall 2025 Investor Conference

Rodent birth control solutions are disrupting a $4.5 billion global market, driven by regulatory bans on poisons and demand for humane alternatives. Evolve, the new top-selling product, has fueled 56% revenue growth and margin expansion, with strong e-commerce and municipal traction. International and government channels are set to accelerate future growth.

7 months ago - Transcripts

SenesTech to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

SURPRISE, Ariz. , Sept. 17, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations, today announced that it will participate in a web...

7 months ago - PRNewsWire

SenesTech's Evolve™ Rat Birth Control Now Available Online at HomeDepot.com

Revolutionary, Non-Toxic Solution Expands Consumer Access and Investor Growth Opportunities SURPRISE, Ariz. , Sept. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility con...

8 months ago - PRNewsWire

SenesTech's Evolve™ Deployments Expanded to Additional Chicago Neighborhoods

SURPRISE, Ariz. , Sept. 2, 2025 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, today confirmed the latest order for its innov...

8 months ago - PRNewsWire

SenesTech Transcript: Lytham Partners Consumer & Technology Summit

A science-driven rodent control company is rapidly expanding with its Evolve soft bait, leveraging regulatory tailwinds, a strong competitive moat, and multi-channel distribution. Revenue and margins are growing, with a robust cash position and clear path to profitability.

9 months ago - Transcripts

SenesTech to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025

SURPRISE, Ariz. , Aug. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcas...

9 months ago - PRNewsWire

SenesTech Earnings Call Transcript: Q2 2025

Record Q2 revenue and gross margins were driven by Evolve's rapid adoption, with e-commerce and municipal sales surging. The company is well-funded, expects continued growth across all channels, and targets cash flow break-even in late 2026.

9 months ago - Transcripts

SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz. , Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES...

9 months ago - PRNewsWire

SenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds

SURPRISE, Ariz. , Aug. 5, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the clo...

9 months ago - PRNewsWire

SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds

SURPRISE, Ariz. , Aug. 5, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the ent...

9 months ago - PRNewsWire

SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX , July 31, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in ferti...

9 months ago - PRNewsWire

SenesTech Announces Closing of Warrant Exercise for $4.4 Million in Gross Proceeds

SURPRISE, Ariz. , July 1, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the clo...

10 months ago - PRNewsWire